Advertisement
Screener

NEXENTIS TECHNOLOGIES INC. (NXTS) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

NEXENTIS TECHNOLOGIES INC. Cash Flow Breakdown

Cash flow breakdown shows where NEXENTIS TECHNOLOGIES INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $3.81M went out.
  • Fiscal year ended 2025-12-31: from investing, $3.23M went out.
  • Fiscal year ended 2025-12-31: from financing, $8.86M came in.
  • Fiscal year ended 2025-12-31: change in cash, $1.80M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backCommercial paperNew shares soldNot split outChange in cash
2025-12-31-$3.81M-$3.23M$175.00K*$8.68M*$1.80M
2024-12-31-$3.42M-$1.89M$3.05M*-$2.27M
2023-12-31-$3.23M-$1.52M$3.47M*-$1.27M
2022-12-31-$5.10M-$51.69K-$8.39K$4.10M-$1.06M
2021-12-31-$4.11M-$67.75K-$7.88K$10.50M$6.54M
2020-12-31-$798.74K-$6.73K-$7.27K$350.00K-$63.71K
2019-12-31-$1.24M-$81.66K-$42.26K$840.69K-$148.99K
2018-12-31-$506.50K$5.78K-$18.94K-$4.46K$914.33K$411.49K

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backCommercial paperNew shares soldNot split outChange in cash
2026-06-30-$539.00K*-$110.00K*$3.95M*
2026-03-31-$1.42M-$450.00K$2.20M*$323.00K
2025-12-31-$1.50M*-$1.33M*$228.00K*$531.00K*
2025-09-30-$974.00K*-$273.00K*-$719.00K*$4.88M*
2025-06-30-$528.00K*-$449.00K*-$191.00K*$1.59M*
2025-03-31-$809.00K-$1.18M$857.00K*$1.68M*$538.00K
2024-12-31-$492.00K*-$516.00K*
2024-09-30-$891.00K*-$1.21M*
2024-06-30-$1.03M*$2.17M*
2024-03-31-$1.01M-$965.00K
2023-12-31-$975.13K*$559.00*
2023-09-30-$624.45K*-$417.89K*
2023-06-30-$528.63K*
2023-03-31-$1.11M-$1.11M
2022-12-31-$970.42K*-$16.26K*-$2.50K*$0.00*
2022-09-30-$1.77M*-$19.75K*-$1.92K*$4.10M*
2022-06-30-$1.27M*$2.18K*-$1.95K*
2022-03-31-$1.09M-$17.86K-$2.02K-$1.11M
2021-12-31-$923.40K*-$43.99K*-$2.05K*$0.00*
2021-09-30-$1.47M*-$28.14K*-$1.98K*$0.00*
2021-06-30-$1.63M*$0.00*-$1.88K*$10.56M*
2021-03-31-$84.55K$4.38K-$1.98K$127.17K
2020-12-31-$179.34K*-$8.54K*-$1.89K*$0.00*
2020-09-30-$150.40K*$2.38K*-$1.83K*
2020-06-30-$235.36K*-$658.00*-$1.77K*
2020-03-31-$233.64K$84.00-$1.79K-$110.81K
2019-12-31-$364.99K*-$20.59K*-$2.03K*$0.00*
2019-09-30-$285.10K*-$10.82K*-$1.71K*$99.99K*
2019-06-30-$267.78K*-$45.77K*-$32.73K*$284.03K*
2019-03-31-$326.89K-$4.48K-$5.79K$456.67K$119.49K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02